Marina Klein



Canada Research Chair in Clinical and Epidemiologic Studies of Chronic Viral Infections in Vulnerable Populations

Tier 1 - 2018-10-01
Renewed: 2025-10-01
McGill University
Canadian Institutes of Health Research

514-843-2090
marina.klein@mcgill.ca

Research involves


Evaluating and implementing interventions to improve health outcomes for people co-infected with hepatitis C and HIV, and influencing policy on care for vulnerable populations.

Research relevance


This research will lead to better access to health care and improved health outcomes for Canadians co-infected with hepatitis C and HIV.

Research Summary


HIV and sexually transmitted and blood-borne infection (STBBI) rates are rising in Canada and globally. Unfortunately, both stigma and geographic and population disparities in care persist. To curb this trend, new tools are needed for prevention, diagnosis, treatment and patient care. As Canada Research Chair in Clinical and Epidemiologic Studies of Chronic Viral Infections in Vulnerable Populations, Dr. Marina Klein aims to develop these tools. 

Klein is leading the Pan-Canadian Network for HIV/AIDS and STBBI Clinical Trials Research. Informed by regional teams and people with lived experience, she and her research team are developing, implementing and evaluating interventions to improve health outcomes for people living with HIV, viral hepatitis and STTBBIs. Their goal is to reduce new infections, ensure comprehensive lifelong care, and lay the groundwork for cures, ultimately paving the way to eliminating these diseases in vulnerable populations.